CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 3,430 shares (option exercise)
- 4 Option exercise Director acquired 3,430 shares (option exercise)
- 4 Option exercise Director acquired 3,430 shares (option exercise)
- 4 Option exercise Director acquired 8,575 shares (option exercise)
- 4 Option exercise Director acquired 3,430 shares (option exercise)
- 4 Option exercise Director acquired 3,430 shares (option exercise)
- 8-K Event Unregistered share sale
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Regulation FD disclosure
Page 2 of 31 · 614 filings